Repligen Corp (RGEN) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Repligen Corp (Repligen) is a bioprocessing life science company that develops and commercializes consumable products for manufacturing biological drugs. The companys products include Protein A affinity resins, Protein A ligands, ELISA kits, alternating tangential flow system, OPUS pre packed chromatography columns, and cell culture supplements. It manufactures Protein A, which is a critical reagent used to manufacture monoclonal antibody therapeutics. Repligens products find application in upstream applications, downstream applications, process intensification, and continuous processing. It caters to biopharmaceutical companies and contract manufacturing organizations. The company operates through its manufacturing facilities located in Lund, Sweden; Ravensberg, Germany; and Shrewsbury and Rancho Dominguez, the US. Repligen is headquartered in Waltham, Massachusetts, the US.

Repligen Corp (RGEN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact